Dan T Vogl (Dan Vogl)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

Nature medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Marcelo C Pasquini, Paul K Wallace, Brent R Logan, Manmeet Kaur, Joseph D Tario, Alan Howard, Yali Zhang, Claudio Brunstein, Yvonne Efebera, Nancy L Geller, Sergio A Giralt, Parameswaran N Hari, Mary M Horowitz, John Koreth, Amrita Y Krishnan, Heather J Landau, George Somlo, Nina Shah, Edward Stadtmauer, Dan T Vogl, David H Vesole, Philip L McCarthy, Theresa Hahn
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Zainul Shoyeb Hasanali, Alfred L Garfall, Lisa Burzenski, Leonard D Shultz, Yan Tang, Siddhant Kadu, Neil C Sheppard, Derek Dopkin, Dan T Vogl, Adam David Cohen, Adam J Waxman, Sandra P Susanibar-Adaniya, Martin P Carroll, Edward A Stadtmauer, David Allman
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice. bioRxiv : the preprint server for biology (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Zainul Shoyeb Hasanali, Alfred L Garfall, Lisa Burzenski, Leonard D Shultz, Yan Tang, Siddhant Kadu, Neil C Sheppard, Derek Dopkin, Dan T Vogl, Adam David Cohen, Adam J Waxman, Sandra P Susanibar-Adaniya, Martin P Carroll, Edward A Stadtmauer, David Allman
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice. bioRxiv : the preprint server for biology (2024)
Zainul Shoyeb Hasanali, Alfred L Garfall, Lisa Burzenski, Leonard D Shultz, Yan Tang, Siddhant Kadu, Neil C Sheppard, Derek Dopkin, Dan T Vogl, Adam David Cohen, Adam J Waxman, Sandra P Susanibar-Adaniya, Martin P Carroll, Edward A Stadtmauer, David Allman
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice. bioRxiv : the preprint server for biology (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T-cell Lymphoma and Secondary Primary Malignancy Risk After Commercial CAR T-cell Therapy. Nature medicine (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)
Marcelo C Pasquini, Paul K Wallace, Brent R Logan, Manmeet Kaur, Joseph D Tario, Alan Howard, Yali Zhang, Claudio Brunstein, Yvonne Efebera, Nancy L Geller, Sergio A Giralt, Parameswaran N Hari, Mary M Horowitz, John Koreth, Amrita Y Krishnan, Heather J Landau, George Somlo, Nina Shah, Edward Stadtmauer, Dan T Vogl, David H Vesole, Philip L McCarthy, Theresa Hahn
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)
Marcelo C Pasquini, Paul K Wallace, Brent R Logan, Manmeet Kaur, Joseph D Tario, Alan Howard, Yali Zhang, Claudio Brunstein, Yvonne Efebera, Nancy L Geller, Sergio A Giralt, Parameswaran N Hari, Mary M Horowitz, John Koreth, Amrita Y Krishnan, Heather J Landau, George Somlo, Nina Shah, Edward Stadtmauer, Dan T Vogl, David H Vesole, Philip L McCarthy, Theresa Hahn
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Cindy Lin, Laura Garcia-Gerique, Erin E Bonner, Jerome Mastio, Matthew Rosenwasser, Zachary Cruz, Michael E Lawler, Luca Bernabei, Kar Muthumani, Jingjing Liu, Mortimer Poncz, Thomas Vogl, Marie Törngren, Helena Eriksson, Dan T Vogl, Dmitry I Gabrilovich, Yulia Nefedova
S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes. Cancer research communications 3 (3) (2023)
Yan Tang, Wei Liu, Siddhant Kadu, Omar Johnson, Zainul Shoyeb Hasanali, Andre R Kelly, Alexander A Shestov, Eli Greenblat, Matthew Holmes, Li-Ping Wang, Natalie Shih, Roddy S O'Connor, Alfred L Garfall, David Allman, Dan T Vogl, Adam David Cohen, Carl H June, Neil C Sheppard
Exploiting the CD200-CD200R Immune Checkpoint Axis in Multiple Myeloma to Enhance CAR-T Therapy. Blood (2023)
Angela Dispenzieri, Amrita Krishnan, Bonnie Arendt, Beth Blackwell, Paul K Wallace, Surendra Dasari, Dan T Vogl, Yvonne A Efebera, Mingwei Fei, Nancy Geller, Sergio A Giralt, Theresa Hahn, Alan Howard, Mindy Kohlhagen, Heather J Landau, Parameswaran N Hari, Marcelo C Pasquini, Muzaffar H Qazilbash, Philip McCarthy, Nina Shah, David H Vesole, Edward Stadtmauer, David L Murray
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT). Blood cancer journal 12 (2) (2022)
Hui Deng, Cindy Lin, Laura Garcia-Gerique, Shuyu Fu, Zachary Cruz, Erin E Bonner, Matthew Rosenwasser, Sridharan Rajagopal, M Naveen Sadhu, Chandru Gajendran, Mohd Zainuddin, Ramachandraiah Gosu, Dhanalakshmi Sivanandhan, Miriam A Shelef, Brian Nam, Dan T Vogl, Dmitry I Gabrilovich, Yulia Nefedova
A Novel Selective Inhibitor JBI-589 Targets PAD4-Mediated Neutrophil Migration to Suppress Tumor Progression. Cancer research 82 (19) (2022)
Mark A Dawson, Gautam Borthakur, Brian James Patrick Huntly, Anastasios Karadimitris, Adrian Alegre, Aristeidis Chaidos, Dan T Vogl, Daniel A Pollyea, Faith E Davies, Gareth J Morgan, Jacob Lowell Glass, Manali Kamdar, Maria-Victoria Mateos-Manteca, Natalia Tovar, Paul Yeh, Regina García Delgado, Faisal Basheer, Ludovica Marando, Paolo Gallipoli, Anastasia Wyce, Anu Shilpa Krishnatry, Olena Barbash, Evi Bakirtzi, Geraldine Ferron-Brady, Natalie O Karpinich, Michael T McCabe, Shawn W Foley, Thierry Horner, Arindam Dhar, Brandon E Kremer, Michael J Dickinson
A phase I/II open-label study of molibresib for the treatment of relapsed/refractory hematologic malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Brian W Hoeynck, Adam D Cohen, Edward A Stadtmauer, Sandra P Susanibar-Adaniya, Dan T Vogl, Adam J Waxman, Mark Bardsley, Samantha Le, Lexis LaMaestra, Alfred L Garfall
Progressive Multifocal Leukoencephalopathy in Multiple Myeloma. European journal of haematology (2022)
Alfred L Garfall, Adam David Cohen, Sandra P Susanibar-Adaniya, Wei-Ting Hwang, Dan T Vogl, Adam J Waxman, Simon F Lacey, Vanessa E Gonzalez, Joseph A Fraietta, Minnal Gupta, Irina Kulikovskaya, Lifeng Tian, Fang Chen, Natalka Koterba, Robert L Bartoszek, Margaret Patchin, Rong Xu, Gabriela Plesa, Donald L Siegel, Andrea Brennan, Anne Marie Nelson, Regina Ferthio, Angela Cosey, Kim-Marie Shea, Rachel Leskowitz, Megan Four, Wesley V Wilson, Fei Miao, Eric Lancaster, Beatriz M Carreno, Gerald P Linette, Elizabeth O Hexner, Regina M Young, Dexiu Bu, Keith G Mansfield, Jennifer L Brogdon, Carl H June, Michael C Milone, Edward A Stadtmauer
Anti-BCMA/CD19 CAR T cells with early immunomodulatory maintenance for multiple myeloma responding to initial or later-line therapy. Blood cancer discovery (2022)
Robert Frank Cornell, Rachid C Baz, Joshua R Richter, Adriana Rossi, Dan T Vogl, Christine Chen, Chaim Shustik, Mariano J Alvarez, Yao Shen, T J Unger, Osnat Ben-Shahar, Hongwei Wang, Erkan Baloglu, William Senapedis, Xiwen Ma, Yosef Landesman, Xiang Bai, Justin Bader, Hongmei Xu, Tracey Marshall, Hua Chang, Christopher J Walker, Jatin Shah, Sharon Shacham, Michael G Kauffman, Craig C Hofmeister
A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma. American journal of hematology (2021)
Alfred L Garfall, Adam David Cohen, Edward Stadtmauer, Sandra P Susanibar-Adaniya, Dan T Vogl, Adam J Waxman
Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Dan T Vogl, Vicki Sallée, Maria C Hendricks, Colleen Redlinger Tabery, Meghan L Blair, Erica Dahlmeier, Emma A Meagher, Roger B Cohen, Robert H Vonderheide
A unique window of opportunity for practical reform of cancer clinical trials. Cancer 127 (16) (2021)
Muzaffar H Qazilbash, Neeraj Y Saini, Cha Soung-Chul, Zhe Wang, Edward Stadtmauer, Veerabhadran Baladandayuthapani, Heather Lin, Beryl Tross, Medhavi Honhar, Sheetal S Rao, Kunhwa Kim, Michael Popescu, Szymon Jakub Szymura, Tiantian Zhang, Aaron J Anderson, Qaiser Bashir, Elizabeth J Shpall, Robert Z Orlowski, Bruce L Levine, Naseem Kerr, Alfred L Garfall, Adam David Cohen, Dan T Vogl, Karen Dengel, Carl H June, Richard E Champlin, Larry W Kwak
A Randomized Phase II Trial of Idiotype Vaccination and Adoptive Autologous T-Cell Transfer in Multiple Myeloma patients. Blood (2021)
Alfred L Garfall, Ehren K Dancy, Adam David Cohen, Wei-Ting Hwang, Joseph A Fraietta, Megan M Davis, Bruce L Levine, Don L Siegel, Edward A Stadtmauer, Dan T Vogl, Adam Waxman, Aaron P Rapoport, Michael C Milone, Carl H June, J Joseph Melenhorst
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma. Blood advances 3 (19) (2020)
Adam David Cohen, Alfred L Garfall, Ahmet Dogan, Simon F Lacey, Chris Martin, Nikoletta Lendvai, Dan T Vogl, Matthew Spear, Alexander M Lesokhin
Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies. Blood advances 3 (16) (2020)
Maria Gavriatopoulou, Ajai Chari, Christine Chen, Nizar Bahlis, Dan T Vogl, Andrzej Jakubowiak, David Dingli, Robert F Cornell, Craig C Hofmeister, David S Siegel, Jesus G Berdeja, Donna Reece, Darrell White, Suzanne Lentzsch, Cristina Gasparetto, Carol Ann Huff, Sundar Jagannath, Rachid Baz, Ajay K Nooka, Joshua Richter, Rafat Abonour, Terri L Parker, Andrew J Yee, Philippe Moreau, Sagar Lonial, Sascha Tuchman, Katja C Weisel, Mohamad Mohty, Sylvain Choquet, T J Unger, Kai Li, Yi Chai, Lingling Li, Jatin Shah, Sharon Shacham, Michael G Kauffman, Meletios Athanasios Dimopoulos
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials. Leukemia 34 (9) (2020)
Marina Li, Cindy Lin, Hui Deng, Joann Strnad, Luca Bernabei, Dan T Vogl, James J Burke, Yulia Nefedova
A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Molecular cancer therapeutics 19 (7) (2020)
Nan Zhou, Alvaro Gutierrez-Uzquiza, Xiang Yu Zheng, Renxu Chang, Dan T Vogl, Alfred L Garfall, Luca Bernabei, Anita Saraf, Laurence Florens, Michael P Washburn, Anuradha Illendula, John H Bushweller, Luca Busino
RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation. Leukemia 33 (8) (2019)